5-hydroxytryptophan has been researched along with Minimal Disease, Residual in 2 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tőke, J | 1 |
Czirják, G | 1 |
Tóth, M | 1 |
Rácz, K | 1 |
Patócs, A | 1 |
Nikolaou, A | 1 |
Thomas, D | 1 |
Kampanellou, C | 1 |
Alexandraki, K | 1 |
Andersson, LG | 1 |
Sundin, A | 1 |
Kaltsas, G | 1 |
1 review available for 5-hydroxytryptophan and Minimal Disease, Residual
Article | Year |
---|---|
[Significance of biochemical markers in the diagnosis of neuroendocrine tumours and for the follow-up of patients].
Topics: 5-Hydroxytryptophan; Biomarkers, Tumor; Chorionic Gonadotropin; Chromogranins; Glucagon; Humans; Hyd | 2014 |
1 other study available for 5-hydroxytryptophan and Minimal Disease, Residual
Article | Year |
---|---|
The value of 11C-5-hydroxy-tryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: experience from one center.
Topics: 5-Hydroxytryptophan; ACTH Syndrome, Ectopic; Adult; Carbon Radioisotopes; Carcinoid Tumor; Female; H | 2010 |